Danielle Keatley
Investor Relations Contact chez STRUCTURE THERAPEUTICS INC.
Profil
Danielle Keatley is currently the Head-Investor Relations at Structure Therapeutics, Inc. Previously, she worked as the Head-Media Relations at Onyx Pharmaceuticals, Inc. from 2012 to 2013.
She also served as the Head-IR & Corporate Communications at Ultragenyx Pharmaceutical, Inc. from 2016 to 2021.
Postes actifs de Danielle Keatley
| Sociétés | Poste | Début |
|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Investor Relations Contact | - |
Anciens postes connus de Danielle Keatley
| Sociétés | Poste | Fin |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Investor Relations Contact | 01/08/2021 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Public Communications Contact | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| STRUCTURE THERAPEUTICS INC. | Commercial Services |
| Entreprise privées | 1 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
